Profile | GDS4284 / 234610_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 185.262 | 48 |
GSM687648 | Patient 402 control | 92.2396 | 34 |
GSM687653 | Patient 403 control | 57.3438 | 26 |
GSM687658 | Patient 404 control | 135.929 | 40 |
GSM687663 | Patient 411 control | 71.6961 | 27 |
GSM687668 | Patient 422 control | 180.68 | 47 |
GSM687673 | Patient 424 control | 86.0584 | 30 |
GSM687678 | Patient 425 control | 171.798 | 44 |
GSM687683 | Patient 427 control | 105.224 | 33 |
GSM687688 | Patient 428 control | 162.113 | 44 |
GSM687695 | Patient 441 control | 278.946 | 47 |
GSM687699 | Patient 443 control | 272.856 | 51 |
GSM687704 | Patient 444 control | 180.923 | 46 |
GSM687707 | Patient 448 control | 246.89 | 49 |
GSM687712 | Patient 449 control | 174.598 | 45 |
GSM687719 | Patient 450 control | 139.066 | 37 |
GSM687724 | Patient 451 control | 154.036 | 40 |
GSM687728 | Patient 452 control | 181.316 | 45 |
GSM687646 | Patient 401 treated 24h | 105.338 | 36 |
GSM687649 | Patient 402 treated 24h | 123.038 | 41 |
GSM687665 | Patient 411 treated 24h | 228.828 | 49 |
GSM687651 | Patient 402 treated 4 weeks | 164.652 | 43 |
GSM687667 | Patient 411 treated 4 weeks | 75.2751 | 29 |
GSM687670 | Patient 422 treated 24h | 172.529 | 44 |
GSM687671 | Patient 422 treated 4 weeks | 113.282 | 38 |
GSM687654 | Patient 403 treated 24h | 166.01 | 47 |
GSM687675 | Patient 424 treated 24h | 148.317 | 40 |
GSM687685 | Patient 427 treated 24h | 47.9786 | 22 |
GSM687656 | Patient 403 treated 4 weeks | 204.432 | 51 |
GSM687677 | Patient 424 treated 4 weeks | 109.937 | 36 |
GSM687687 | Patient 427 treated 4 weeks | 136.347 | 43 |
GSM687692 | Patient 428 treated 4h | 170.103 | 45 |
GSM687716 | Patient 449 treated 4h | 11.0883 | 5 |
GSM687722 | Patient 450 treated 4h | 133.024 | 36 |
GSM687680 | Patient 425 treated 24h | 134.239 | 40 |
GSM687690 | Patient 428 treated 24h | 6.4575 | 3 |
GSM687700 | Patient 443 treated 24h | 215.456 | 42 |
GSM687705 | Patient 444 treated 24h | 114.912 | 39 |
GSM687714 | Patient 449 treated 24h | 132.155 | 42 |
GSM687721 | Patient 450 treated 24h | 170.476 | 41 |
GSM687682 | Patient 425 treated 4 weeks | 136.199 | 42 |
GSM687694 | Patient 428 treated 4 weeks | 190.637 | 49 |
GSM687702 | Patient 443 treated 4 weeks | 268.505 | 52 |
GSM687718 | Patient 449 treated 4 weeks | 137.564 | 40 |
GSM687723 | Patient 450 treated 4 weeks | 205.795 | 48 |
GSM687661 | Patient 404 treated 4h | 89.4031 | 31 |
GSM687710 | Patient 448 treated 4h | 225.98 | 51 |
GSM687726 | Patient 451 treated 4h | 63.4959 | 24 |
GSM687730 | Patient 452 treated 4h | 65.7119 | 16 |
GSM687660 | Patient 404 treated 24h | 269.876 | 51 |
GSM687697 | Patient 441 treated 24h | 77.0101 | 24 |
GSM687709 | Patient 448 treated 24h | 16.8497 | 9 |
GSM687725 | Patient 451 treated 24h | 230.256 | 48 |
GSM687729 | Patient 452 treated 24h | 134.693 | 33 |
GSM687727 | Patient 451 treated 4 weeks | 159.639 | 40 |
GSM687731 | Patient 452 treated 4 weeks | 77.5297 | 27 |